The stocks of TRI have their price target increased by research analysts working at Scotiabank from a sum of $122 to a sum of $128 in a Wednesday research report. Currently, the stock has a rating of “outperform” as set by the brokerage. The price target set by Scotiabank indicates an increase of 32.84% from the previous close of the company.
The Stock Commentary Of TRI
There have been quite a few research equities that have commented on the stocks of TRI. TD Securities has already increased the price target of the company from $125 to $130, with a rating of buy in a Wednesday research report. Morgan Stanley has also increased the price target of the company from $92 to $96 with a rating of equal weight in a Wednesday research report. CIBC has also reduced the rating of Thomson Reuters from outperform to neutral with a price target of $102 in a Thursday research report. BMO Capital Markets has also increased the price target from $116 to $127 with a rating of “outperform” in a 24th February research report.
One of the research equities provided the company with a rating of sell, while four others have given the company a rating of hold. Around seven other analysts have given the company a rating of buy. Currently, TRI Has a buy price rating with a $102.50 price target.
The stocks of TRI traded on Wednesday at $0.36. The market cap of the firm is $47.68 billion, with a 25.61 PE ratio, and a 3.15 PEG ratio. The moving average price of the company over a period of 50 days is $90.33, with the moving average price over 200 days set at $99.14. The current ratio of the company is 1.51.
